Opportunity Information: Apply for RFA CA 19 012
The Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3) opportunity (RFA-CA-19-012) is a National Institutes of Health cooperative agreement tied to the Beau Biden Cancer Moonshot initiative, with the broader aim of speeding up cancer research that can move quickly from discovery to practical clinical impact. The program is built around expanding the Immuno-Oncology Translational Network into an integrated set of multidisciplinary, highly collaborative teams. In plain terms, NIH is looking to fund projects that bring together complementary expertise (for example, immunology, cancer biology, genetics, bioinformatics, translational science, and preclinical modeling) to push immuno-oncology ideas forward in a coordinated, networked way rather than as isolated single-lab efforts.
Scientifically, the focus is on translational research into both innate and adaptive immune mechanisms that influence how tumors start and how they progress. A key emphasis is immunoprevention, meaning strategies that can prevent cancer from developing or progressing by shaping immune responses, alongside immunotherapy approaches that can treat or control disease once it is underway. The FOA explicitly encourages evaluation of new or improved immunopreventive and immunotherapeutic strategies, including combination approaches that pair immune-based interventions with standard treatments or other therapies. While the exact therapeutic modality is not limited in the text provided, the intent is clearly to support work where an immune target or approach is pursued with a realistic line of sight to testing in people, after credible preclinical evidence is generated.
The studies supported under this announcement are expected to be largely preclinical, but not purely exploratory or disconnected from clinical reality. NIH signals that projects should use clinically relevant models and clinically meaningful endpoints, and they should be designed with the potential for rapid translation into early-phase clinical applications. That typically implies careful attention to things like mechanism-of-action evidence, biomarkers or immune correlates that could be tracked in humans later, dosing or regimen rationale, safety considerations that can be assessed preclinically, and models that better resemble human disease biology than simple proof-of-concept systems. The overall bar is not just novelty, but readiness to move along a translational path.
The funding structure is a phased UG3/UH3 model, and applicants are required to submit a single application that covers both phases together. The UG3 phase supports exploratory work aimed at immune target identification and validation, essentially the work needed to justify a specific intervention strategy and to de-risk the concept before more resource-intensive development. Progression is milestone-driven: investigators must meet defined milestones (the text references “UH2 milestones” as the gate for transition; the core idea is that there are concrete, pre-specified benchmarks) before the project can move into the UH3 implementation phase. Transition to UH3 is not automatic; it occurs after an administrative review of whether the milestones were achieved. If the milestones are met, the UH3 phase can proceed with development and preclinical testing of specific interventions, pushing the project closer to the point where an early-phase clinical study could be justified.
Administratively, this opportunity is categorized as a discretionary program and uses a cooperative agreement funding instrument, which generally means NIH expects substantial programmatic involvement compared with a standard grant. In practice, cooperative agreements often come with coordination expectations, shared network activities, and closer interaction with NIH staff to keep projects aligned with network goals, timelines, and deliverables. The activity category listed is Education, Environment, Health, and multiple CFDA numbers are associated with it (93.113, 93.121, 93.353, 93.393, 93.853), reflecting NIH program structures that can support cancer and related biomedical research.
Eligibility is broad across U.S.-based organizations and government entities, including state, county, and local governments; public and private institutions of higher education; independent school districts; special district governments; federally recognized Native American tribal governments; certain tribal organizations; public housing/Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses as well as small businesses); and other eligible entities as specified. The FOA also highlights additional eligible institution types often emphasized in federal funding priorities, including Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, and U.S. territories or possessions. At the same time, it draws a clear boundary on foreign eligibility: non-U.S. entities (foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components are allowed as defined by the NIH Grants Policy Statement, meaning a U.S. applicant may, under NIH rules, include certain foreign collaborations or elements if appropriately justified and compliant.
From the source details provided, the original closing date for applications was February 11, 2019, and the FOA was created October 31, 2018. The listed award ceiling is $500,000, and the “expected awards” field is not specified in the provided data. Overall, the opportunity is designed for teams that can start with strong immune target discovery and validation work, hit rigorous go/no-go milestones, and then advance to focused development and preclinical testing of an immunopreventive or immunotherapeutic intervention with a realistic pathway toward early clinical translation within the broader IOTN network structure.Apply for RFA CA 19 012
- The National Institutes of Health in the education, environment, health sector is offering a public funding opportunity titled "Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.121, 93.353, 93.393, 93.853.
- This funding opportunity was created on 2018-10-31.
- Applicants must submit their applications by 2019-02-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Environment, Health
Next opportunity: Volunteer for India: Creating a Young Citizens’ Volunteer Action Corps
Previous opportunity: Voluntary Family Planning for Improved Reproductive Health and Development.
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 19 012
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 19 012) also looked into and applied for these:
| Funding Opportunity |
|---|
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) Apply for PAR 19 051 Funding Number: PAR 19 051 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Research Project Grant (Parent R01 Clinical Trial Required) Apply for PA 19 055 Funding Number: PA 19 055 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) Apply for PA 19 053 Funding Number: PA 19 053 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $200,000 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) Apply for PA 19 054 Funding Number: PA 19 054 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $200,000 |
| NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) Apply for PA 19 052 Funding Number: PA 19 052 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $50,000 |
| NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) Apply for PA 19 091 Funding Number: PA 19 091 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) Apply for PA 19 092 Funding Number: PA 19 092 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $200,000 |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required) Apply for PA 19 088 Funding Number: PA 19 088 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) Apply for PAR 19 098 Funding Number: PAR 19 098 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) Apply for PA 19 121 Funding Number: PA 19 121 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) Apply for PA 19 122 Funding Number: PA 19 122 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) Apply for PA 19 131 Funding Number: PA 19 131 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) Apply for PA 19 132 Funding Number: PA 19 132 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional) Apply for RFA CA 19 009 Funding Number: RFA CA 19 009 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $150,000 |
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) Apply for PAR 19 158 Funding Number: PAR 19 158 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Summer Research Education Experience Program (Clinical Trials Not Allowed R25) Apply for PAR 19 164 Funding Number: PAR 19 164 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $100,000 |
| Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) Apply for PA 19 187 Funding Number: PA 19 187 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) Apply for PAR 19 197 Funding Number: PAR 19 197 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $100,000 |
| Building Interdisciplinary Research Careers in Women's Health (BIRCWH); K12 Clinical Trial Optional Apply for RFA OD 19 020 Funding Number: RFA OD 19 020 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $600,000 |
| Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional) Apply for PAR 19 252 Funding Number: PAR 19 252 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 19 012", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.